Effect of Pod e-Cigarettes vs Cigarettes on Carcinogen Exposure among African American and Latinx Smokers: A Randomized Clinical Trial

JAMA Network Open

Volumn 3, Issue 11, 2020, Pages

  Pulvers, Kim ^a   Nollen, Nicole L ^b   Rice, Myra ^a   Schmid, Christopher H ^c   Qu, Kexin ^c   Benowitz, Neal L ^d   Ahluwalia, Jasjit S ^e  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; CARBON MONOXIDE; CIGARETTE SMOKE; COTININE; NICOTINE; NITROSAMINE; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTAN-1-OL; CARCINOGEN;

ADULT; AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HARM REDUCTION; HEALTH DISPARITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; BREATH ANALYSIS; CIGARETTE SMOKING; ELECTRONIC CIGARETTE; HISPANIC; MAXIMAL MID EXPIRATORY FLOW; METABOLISM; MIDDLE AGED; TOBACCO; URINE; VAPING;

ADULT; AFRICAN AMERICANS; BLOOD PRESSURE; BREATH TESTS; CARBON MONOXIDE; CARCINOGENS; CIGARETTE SMOKING; COTININE; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HARM REDUCTION; HISPANIC AMERICANS; HUMANS; MALE; MAXIMAL MIDEXPIRATORY FLOW RATE; MIDDLE AGED; NITROSAMINES; TOBACCO PRODUCTS; VAPING;

EID: 85096456710     PISSN: None     EISSN: 25743805     Source Type: Journal    
DOI: 10.1001/jamanetworkopen.2020.26324     Document Type: Article

References (35)

1. Brady BR, De La Rosa JS, Nair US, Leischow SJ. Electronic cigarette policy recommendations: a scoping review. Am J Health Behav. 2019; 43 (1): 88-104. doi: 10.5993/AJHB.43.1.8 30522569
2. Huang J, Duan Z, Kwok J, Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tob Control. 2019; 28 (2): 146-151. doi: 10.1136/tobaccocontrol-2018-054382 29853561
3. Herzog B. Wall Street tobacco industry update. Accessed June 2, 2020. http://www.natocentral.org/uploads/Wall_Street_Update_Slide_Deck_February_2019.pdf
4. 1H NMR spectroscopy. Chem Res Toxicol. 2018; 31 (6): 431-434. doi: 10.1021/acs.chemrestox.8b00097 29775302
5. Omaiye EE, McWhirter KJ, Luo W, Pankow JF, Talbot P. High-nicotine electronic cigarette products: toxicity of JUUL fluids and aerosols correlates strongly with nicotine and some flavor chemical concentrations. Chem Res Toxicol. 2019; 32 (6): 1058-1069. doi: 10.1021/acs.chemrestox.8b00381 30896936
6. Walley SC, Wilson KM, Winickoff JP, Groner J. A public health crisis: electronic cigarettes, vape, and JUUL. Pediatrics. 2019; 143 (6):e20182741. doi: 10.1542/peds.2018-2741 31122947
7. Krishnan-Sarin S, Jackson A, Morean M, e-Cigarette devices used by high-school youth. Drug Alcohol Depend. 2019; 194: 395-400. doi: 10.1016/j.drugalcdep.2018.10.022 30497057
8. Stratton K, Kwan LY, Eaton DL. Public Health Consequences of e-Cigarettes: Consensus Study Report. National Academies Press; 2018.
9. Haiman CA, Stram DO, Wilkens LR, Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006; 354 (4): 333-342. doi: 10.1056/NEJMoa033250 16436765
10. Cunningham TJ, Croft JB, Liu Y, Lu H, Eke PI, Giles WH. Vital signs: racial disparities in age-specific mortality among blacks or African Americans-United States, 1999-2015. MMWR Morb Mortal Wkly Rep. 2017; 66 (17): 444-456. 28472021
11. Friedman AS, Horn SJL. Socioeconomic disparities in electronic cigarette use and transitions from smoking. Nicotine Tob Res. 2019; 21 (10): 1363-1370. doi: 10.1093/ntr/nty120 29917124
12. Harlow AF, Stokes A, Brooks DR. Socioeconomic and racial/ethnic differences in e-cigarette uptake among cigarette smokers: longitudinal analysis of the Population Assessment of Tobacco and Health (PATH) study. Nicotine Tob Res. 2019; 21 (10): 1385-1393. doi: 10.1093/ntr/nty141 29986109
13. Giovenco DP. Different smokes for different folks: e-cigarettes and tobacco disparities. Am J Public Health. 2019; 109 (9): 1162-1163. doi: 10.2105/AJPH.2019.305250 31390250
14. Dumville JC, Hahn S, Miles JN, Torgerson DJ. The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials. 2006; 27 (1): 1-12. doi: 10.1016/j.cct.2005.08.003 16236557
15. Avins AL. Can unequal be more fair: ethics, subject allocation, and randomised clinical trials. J Med Ethics. 1998; 24 (6): 401-408. doi: 10.1136/jme.24.6.401 9873981
16. Baker TB, Piper ME, McCarthy DE,; Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence. Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res. 2007; 9 (suppl 4): S555-S570. doi: 10.1080/14622200701673480 18067032
17. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström K-O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86 (9): 1119-1127. doi: 10.1111/j.1360-0443.1991.tb01879.x 1932883
18. Xia Y, McGuffey JE, Bhattacharyya S, Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Anal Chem. 2005; 77 (23): 7639-7645. doi: 10.1021/ac058027u 16316171
19. Byrd GD, Davis RA, Ogden MW. A rapid LC-MS-MS method for the determination of nicotine and cotinine in serum and saliva samples from smokers: validation and comparison with a radioimmunoassay method. J Chromatogr Sci. 2005; 43 (3): 133-140. doi: 10.1093/chromsci/43.3.133 15842752
20. Pulvers K, Emami AS, Nollen NL, Tobacco consumption and toxicant exposure of cigarette smokers using electronic cigarettes. Nicotine Tob Res. 2018; 20 (2): 206-214. doi: 10.1093/ntr/ntw333 28003511
21. Sobell LC, Sobell MB. Timeline Followback: User's Guide. Addiction Research Foundation; 1996.
22. Brown RA, Burgess ES, Sales SD, Whiteley JA, Evans DM, Miller IW. Reliability and validity of a smoking timeline follow-back interview. Psychol Addict Behav. 1998; 12 (2): 101-112. doi: 10.1037/0893-164X.12.2.101
23. Riley CM, Wenzel SE, Castro M, Clinical implications of having reduced mid forced expiratory flow rates (FEF25-75), independently of FEV1, in adult patients with asthma. PLoS One. 2015; 10 (12):e0145476. doi: 10.1371/journal.pone.0145476 26717486
24. Cassidy RN, Roberts ME, Colby SM. Validation of a respiratory symptom questionnaire in adolescent smokers. Tob Regul Sci. 2015; 1 (2): 121-128. doi: 10.18001/TRS.1.2.2 26236764
25. Comstock GW, Tockman MS, Helsing KJ, Hennesy KM. Standardized respiratory questionnaires: comparison of the old with the new. Am Rev Respir Dis. 1979; 119 (1): 45-53. doi: 10.1164/arrd.1979.119.1.45 420437
26. Goniewicz ML, Smith DM, Edwards KC, Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Netw Open. 2018; 1 (8):e185937. doi: 10.1001/jamanetworkopen.2018.5937 30646298
27. Goniewicz ML, Gawron M, Smith DM, Peng M, Jacob P III, Benowitz NL. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study. Nicotine Tob Res. 2017; 19 (2): 160-167. doi: 10.1093/ntr/ntw160 27613896
28. Czoli CD, Fong GT, Goniewicz ML, Hammond D. Biomarkers of exposure among "dual users" of tobacco cigarettes and electronic cigarettes in Canada. Nicotine Tob Res. 2019; 21 (9): 1259-1266. doi: 10.1093/ntr/nty174 30203076
29. McRobbie H, Phillips A, Goniewicz ML, Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prev Res (Phila). 2015; 8 (9): 873-878. doi: 10.1158/1940-6207.CAPR-15-0058 26333731
30. Shahab L, Goniewicz ML, Blount BC, Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study. Ann Intern Med. 2017; 166 (6): 390-400. doi: 10.7326/M16-1107 28166548
31. Piper ME, Baker TB, Benowitz NL, Jorenby DE. Changes in use patterns over 1 year among smokers and dual users of combustible and electronic cigarettes. Nicotine Tob Res. 2020; 22 (5): 672-680. doi: 10.1093/ntr/ntz065 31058284
32. Piper ME, Baker TB, Benowitz NL, Kobinsky KH, Jorenby DE. Dual users compared to smokers: Demographics, dependence, and biomarkers. Nicotine Tob Res. 2019; 21 (9): 1279-1284. doi: 10.1093/ntr/nty231 30365010
33. Sakamaki-Ching S, Williams M, Hua M, Correlation between biomarkers of exposure, effect and potential harm in the urine of electronic cigarette users. BMJ Open Respir Res. 2020; 7 (1):e000452. doi: 10.1136/bmjresp-2019-000452 32079607
34. Inoue-Choi M, Liao LM, Reyes-Guzman C, Hartge P, Caporaso N, Freedman ND. Association of long-term, low-intensity smoking with all-cause and cause-specific mortality in the National Institutes of Health-AARP Diet and Health Study. JAMA Intern Med. 2017; 177 (1): 87-95. doi: 10.1001/jamainternmed.2016.7511 27918784
35. Inoue-Choi M, Hartge P, Liao LM, Caporaso N, Freedman ND. Association between long-term low-intensity cigarette smoking and incidence of smoking-related cancer in the National Institutes of Health-AARP cohort. Int J Cancer. 2018; 142 (2): 271-280. doi: 10.1002/ijc.31059 28929489